drugset / Trial / NCT06561438

Postoperative Pain Management Following Laparoscopic Cholecystectomy

NCT06561438

Phase 3 Completed 86 enrolled Future University in Egypt
RandomizedParallel-groupOpen-labelTreatment

Summary

Postoperative pain management is essential and the inability to treat acute pain appropriately in the first 48 postoperative hours represents a risk factor for developing chronic pain. No. study has investigated Vortioxetine as an adjuvant to standard care for postoperative pain management in patients undergoing LC

Timeline

Start
2024-08-06
Primary completion
2025-06-07
Completion
2025-06-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Vortioxetine Unknown 20 mg Oral

Indications

No indication recorded.